Financial Result for the quarter ended June 30, 2026

July 23, 2026 General Manager, The Manager, Listing Department, Listing & Compliance Department Bombay Stock Exchange Limited, The National Stock Exchange of India Limited P.J. Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex, Mumbai – 400 001 Bandra East, Mumbai - 400051 Company code: 533333 Company code: FCL Subject: Outcome of Board Meeting Dear Sir/Madam, Pursuant to regulation 30, 33 and schedule III (Part A) of SEBI (Listing Obligations and Disclosures) Regulations, 2015, we wish to inform you that the meeting of the Board of Directors held on July 23, 2026, which commenced at 3.50 P.M. and concluded at 5.00 P.M. has inter-alia considered and approved; 1. The Unaudited Standalone and Consolidated financial results and the Limited Review Reports of the Statutory Auditors thereon for the quarter ended June 30, 2026; We enclosed a copy of the Standalone and Consolidated Unaudited Financial Results along with the Limited Review Report of the Statutory Auditors thereon for the quarter ended June 30, 2026. Page No. 1 Highlights of Consolidated Business Consolidated Quarter Q1-FY 2026-2027 (Y-o-Y Basis) 1. Total Income from Operation for the Quarter has increased to Rs. 38,672 Lakhs from Rs. 14,622 Lakhs i.e., a growth of 164.48 %. 2. Operational EBITDA for the quarter has increased to ~Rs. 5,914 Lakhs from ~Rs. 2,520 Lakhs i.e., a growth of ~ 134.74 %. 3. Profit after tax (PAT) for the quarter ended has increased to Rs. 4,821 Lakhs from Rs. 2,503 Lakhs i.e., a growth of 92.61 %. Other Highlights of Q1 for the Financial Year 2026-2027 1. The consolidated Return on Invested Capital (ROIC) for Q1-FY 2026-2027 is ~ 33.06 %. 2. Volume Growth: The volume of the consolidated business for the Quarter ended has increased by~ 130.84% on Y-o-Y basis. Kindly take the above information on your records and oblige. Thanking you, Yours faithfully, For FINEOTEX CHEMICAL LIMITED Sanjay Tibrewala Executive Director and CFO DIN: 00218525 Encl: As above Page No. 2 302. Eco Space. Off Old Nagardas Road. Mogra Lane. Andheri (East). Mumbai -400069 (INDIA) ~ : + 91-22-4047 3900 ; 4047 3940 }lS£ & Co. Fax : + 91-22-4047 3939 E-mail : info@aslco.in Chartered Accountants Independent Auditor's Review Report on the Consolidated Unaudited Quarterly Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. Review Report to The Board of Directors Fineotex Chemical Limited 1. We have reviewed the accompanying Statement of Consolidated Unaudited financial results of Fineotex Chemical Limited (the "Parent") and its subsidiaries (the Parent and its subsidiaries together referred to as "the Group"), for the quarter ended June 30, 2026 (the "Statement") attached herewith, being submitted by the Parent pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "Listing Regulations"). 2. This Statement, which is the responsibility of the Parent's Management and approved by the Parent's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, (lnd AS 34) "Interim Financial Reporting "prescribed under Section 133 of the Companies Act, 2013 ("the Act") as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our reVIew. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity, issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing specified under Section 143(10) of the Act, and consequently, does not enable us to obtain assurance that· we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the SEBI Circular CIRlCFD/CMD1I44/2019 dated 29 March 2019 issued by the SEBI under Regulation 33 (8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 20 15 (as amended), to the extent applicable. Page 1 of 3 Continuation Sheel fiSL & CO. Chartered Accountants Fineotex Chemical Limited Independent Auditor's Review Report on the Consolidated Unaudited Quarterly Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. 4. The Statement includes the results of the following entities: Name of Entities Relationship 1. Manya Manufacturing India Private Limited Wholly Owned Subsidiary (Formerly Known as Manya Steels Private Limited) 2. Fineotex Biotex Healthguard FZE Wholly Owned Subsidiary (Formerly Known as Fineotex Specialities FZE) 3. Fineotex Malaysia Limited Wholly Owned Subsidiary 4. FSPL Specialities Private Limited Wholly Owned Subsidiary (Formerly Known as Fineotex Specialities Private Limited) 5. Finoclean Specialities Private Limited Wholly Owned Subsidiary Subsidiaries of Fineotex Malaysia Limited 6. BT Chemicals SDN.BHD. Subsidiary 7. BT Biotex SDN.BHD. Subsidiary 8. Rovatex SDN: BHD. Subsidiary 9. BT. Biotex Limited Wholly Owned Subsidiary Subsidiaries of Fineotex Biotex Healthguard FZE 10. CrudeChem Technology LLC Subsidiary 11. FrackMex Equipment and Services LLC Subsidiary 12. Lonestar Technoboost LLC Subsidiary 13. Oil Pro Advantage INC Subsidiary 5. Based on our review conducted and procedures performed as stated in paragraph 3 above and based on the consideration of the unreviewed and unaudited interim financial information prepared and furnished to us by the management and approved by the Board of Directors of the Parent Company referred to in paragraph 6 below, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Ind AS 34 specified under Section 133 of the Act, as amended, read with relevant rules issued thereunder and other recognized accounting practices and policies generally accepted in India has not disclosed the information required to be disclosed in terms of the Listing Regulations including the manner in which it is to be disclosed, or that it contains any material misstatement. Page 2 of 3 Continuation Sheel fiS L & CO. Chartered Accountants Fineotex Chemical Limited Independent Auditor's Review Report on the Consolidated Unaudited Quarterly Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. 6. The consolidated unaudited financial results includes the interim financial information of Thirteen subsidiaries which have not been reviewed and are not audited, whose interim financial information reflects (before eliminating intercompany transactions) total revenue of ~. 31,082.51 Lakhs and total profit after tax of~. 2,767.94 Lakhs for the quarter ended June 30, 2026, as considered in the consolidated unaudited financial results. These interim financial information are" not reviewed and are unaudited and have been prepared and furnished to us by the management of the Parent Company and our opinion on the unaudited consolidated financial results, In so far as it relates to the amounts included in the co [Showing first 8,000 characters — download PDF for full document]